Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Curis (CRIS) Research & Development (2016 - 2025)

Curis (CRIS) has disclosed Research & Development for 16 consecutive years, with $6.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development fell 33.85% year-over-year to $6.4 million, compared with a TTM value of $31.4 million through Sep 2025, down 20.63%, and an annual FY2024 reading of $38.6 million, down 2.36% over the prior year.
  • Research & Development was $6.4 million for Q3 2025 at Curis, down from $7.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $12.3 million in Q2 2022 and bottomed at $6.4 million in Q3 2025.
  • Average Research & Development over 5 years is $9.4 million, with a median of $9.6 million recorded in 2024.
  • The sharpest move saw Research & Development skyrocketed 92.08% in 2021, then tumbled 33.85% in 2025.
  • Year by year, Research & Development stood at $10.8 million in 2021, then dropped by 19.18% to $8.7 million in 2022, then increased by 14.45% to $10.0 million in 2023, then decreased by 10.0% to $9.0 million in 2024, then decreased by 28.28% to $6.4 million in 2025.
  • Business Quant data shows Research & Development for CRIS at $6.4 million in Q3 2025, $7.5 million in Q2 2025, and $8.5 million in Q1 2025.